I'm not sure about that
@MrAdem I can't recall spikes immediately ahead of an announcement. I can regularly recall price drops after an announcement though, even if it was good.
If good results, this will be a genuine watershed moment for ResApp. It will also help with getting the FDA onside for Dx. Don't forget that TK has admitted to exploring fast approval pathways to get this to commercialisation. The FDA's EAP program. Sadly Covid seems to continue to rear its ugly head at the moment. I hate to take world pain as opportunity for us, but that maybe how it is panning out.
